nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—P-Glycoprotein Inhibitors—Everolimus—kidney cancer	0.18	0.352	CiPCiCtD
Cyclosporine—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.166	0.324	CiPCiCtD
Cyclosporine—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.166	0.324	CiPCiCtD
Cyclosporine—FKBP1A—Everolimus—kidney cancer	0.0776	0.254	CbGbCtD
Cyclosporine—FKBP1A—Temsirolimus—kidney cancer	0.0524	0.172	CbGbCtD
Cyclosporine—ABCB1—kidney cancer	0.0296	1	CbGaD
Cyclosporine—ABCC10—Gemcitabine—kidney cancer	0.0101	0.0331	CbGbCtD
Cyclosporine—ABCC10—Paclitaxel—kidney cancer	0.00913	0.0299	CbGbCtD
Cyclosporine—ABCC10—Vincristine—kidney cancer	0.00787	0.0258	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.00508	0.0166	CbGbCtD
Cyclosporine—CYP3A7—Temsirolimus—kidney cancer	0.00508	0.0166	CbGbCtD
Cyclosporine—ABCB11—Paclitaxel—kidney cancer	0.00496	0.0162	CbGbCtD
Cyclosporine—ABCC3—Vincristine—kidney cancer	0.00495	0.0162	CbGbCtD
Cyclosporine—ABCC1—Dactinomycin—kidney cancer	0.00494	0.0162	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—kidney cancer	0.00492	0.0161	CbGbCtD
Cyclosporine—SLCO1B1—Pazopanib—kidney cancer	0.00455	0.0149	CbGbCtD
Cyclosporine—ABCB11—Vinblastine—kidney cancer	0.00435	0.0142	CbGbCtD
Cyclosporine—ABCB11—Vincristine—kidney cancer	0.00428	0.014	CbGbCtD
Cyclosporine—CYP3A5—Temsirolimus—kidney cancer	0.00381	0.0125	CbGbCtD
Cyclosporine—ABCG2—Pazopanib—kidney cancer	0.00361	0.0118	CbGbCtD
Cyclosporine—ABCC1—Paclitaxel—kidney cancer	0.00353	0.0115	CbGbCtD
Cyclosporine—ABCG2—Dactinomycin—kidney cancer	0.0033	0.0108	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—kidney cancer	0.00309	0.0101	CbGbCtD
Cyclosporine—ABCC1—Vinblastine—kidney cancer	0.00309	0.0101	CbGbCtD
Cyclosporine—ABCC1—Vincristine—kidney cancer	0.00304	0.00995	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—kidney cancer	0.00267	0.00875	CbGbCtD
Cyclosporine—ABCC2—Paclitaxel—kidney cancer	0.00261	0.00854	CbGbCtD
Cyclosporine—ABCG2—Erlotinib—kidney cancer	0.00258	0.00843	CbGbCtD
Cyclosporine—ABCB1—Temsirolimus—kidney cancer	0.00248	0.00811	CbGbCtD
Cyclosporine—ABCG2—Paclitaxel—kidney cancer	0.00236	0.00772	CbGbCtD
Cyclosporine—CYP2D6—Temsirolimus—kidney cancer	0.00234	0.00765	CbGbCtD
Cyclosporine—ABCC2—Sorafenib—kidney cancer	0.00232	0.00759	CbGbCtD
Cyclosporine—ABCC2—Vinblastine—kidney cancer	0.00229	0.00749	CbGbCtD
Cyclosporine—ABCC2—Vincristine—kidney cancer	0.00225	0.00736	CbGbCtD
Cyclosporine—CYP3A4—Everolimus—kidney cancer	0.0022	0.0072	CbGbCtD
Cyclosporine—ABCG2—Sorafenib—kidney cancer	0.0021	0.00686	CbGbCtD
Cyclosporine—PPP3CA—nephron—kidney cancer	0.00204	0.0669	CbGeAlD
Cyclosporine—ABCG2—Vincristine—kidney cancer	0.00203	0.00666	CbGbCtD
Cyclosporine—CYP2C8—Pazopanib—kidney cancer	0.00192	0.0063	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—kidney cancer	0.0019	0.00622	CbGbCtD
Cyclosporine—ABCC2—Sunitinib—kidney cancer	0.00188	0.00615	CbGbCtD
Cyclosporine—CYP3A7—Paclitaxel—kidney cancer	0.00174	0.0057	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00174	0.0057	CbGbCtD
Cyclosporine—ABCG2—Sunitinib—kidney cancer	0.0017	0.00556	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00155	0.00507	CbGbCtD
Cyclosporine—CYP3A7—Sorafenib—kidney cancer	0.00155	0.00507	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0015	0.00492	CbGbCtD
Cyclosporine—CYP3A7—Vincristine—kidney cancer	0.0015	0.00492	CbGbCtD
Cyclosporine—CYP3A4—Temsirolimus—kidney cancer	0.00149	0.00486	CbGbCtD
Cyclosporine—PPP3R2—gonad—kidney cancer	0.00147	0.0482	CbGeAlD
Cyclosporine—CYP3A5—Erlotinib—kidney cancer	0.00143	0.00467	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—kidney cancer	0.00141	0.0046	CbGbCtD
Cyclosporine—CYP2C9—Capecitabine—kidney cancer	0.0014	0.00458	CbGbCtD
Cyclosporine—CYP2C8—Erlotinib—kidney cancer	0.00137	0.00449	CbGbCtD
Cyclosporine—CYP3A5—Paclitaxel—kidney cancer	0.00131	0.00428	CbGbCtD
Cyclosporine—ABCB1—Pazopanib—kidney cancer	0.0013	0.00426	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—kidney cancer	0.00127	0.00416	CbGbCtD
Cyclosporine—CYP2C8—Paclitaxel—kidney cancer	0.00126	0.00411	CbGbCtD
Cyclosporine—CYP3A7—Sunitinib—kidney cancer	0.00125	0.0041	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00125	0.0041	CbGbCtD
Cyclosporine—CYP2D6—Pazopanib—kidney cancer	0.00123	0.00402	CbGbCtD
Cyclosporine—ABCB1—Dactinomycin—kidney cancer	0.00119	0.0039	CbGbCtD
Cyclosporine—CYP3A5—Sorafenib—kidney cancer	0.00116	0.0038	CbGbCtD
Cyclosporine—CYP3A5—Vincristine—kidney cancer	0.00113	0.00369	CbGbCtD
Cyclosporine—CYP2C8—Sorafenib—kidney cancer	0.00112	0.00365	CbGbCtD
Cyclosporine—ABCB1—Gemcitabine—kidney cancer	0.000942	0.00308	CbGbCtD
Cyclosporine—CYP3A5—Sunitinib—kidney cancer	0.000941	0.00308	CbGbCtD
Cyclosporine—CYP2C19—Sorafenib—kidney cancer	0.000936	0.00306	CbGbCtD
Cyclosporine—ABCB1—Erlotinib—kidney cancer	0.000929	0.00304	CbGbCtD
Cyclosporine—CYP2C9—Paclitaxel—kidney cancer	0.000877	0.00287	CbGbCtD
Cyclosporine—CYP2D6—Erlotinib—kidney cancer	0.000876	0.00287	CbGbCtD
Cyclosporine—ABCB1—Paclitaxel—kidney cancer	0.000851	0.00278	CbGbCtD
Cyclosporine—CYP3A4—Pazopanib—kidney cancer	0.00078	0.00255	CbGbCtD
Cyclosporine—CYP2C9—Sorafenib—kidney cancer	0.000779	0.00255	CbGbCtD
Cyclosporine—ABCB1—Sorafenib—kidney cancer	0.000756	0.00247	CbGbCtD
Cyclosporine—ABCB1—Vinblastine—kidney cancer	0.000746	0.00244	CbGbCtD
Cyclosporine—ABCB1—Vincristine—kidney cancer	0.000734	0.0024	CbGbCtD
Cyclosporine—CYP2D6—Sorafenib—kidney cancer	0.000712	0.00233	CbGbCtD
Cyclosporine—CYP2D6—Vinblastine—kidney cancer	0.000703	0.0023	CbGbCtD
Cyclosporine—SLC10A2—nephron tubule—kidney cancer	0.000691	0.0227	CbGeAlD
Cyclosporine—FKBP4—nephron tubule—kidney cancer	0.000685	0.0225	CbGeAlD
Cyclosporine—PPID—nephron tubule—kidney cancer	0.000632	0.0207	CbGeAlD
Cyclosporine—SLC10A2—renal system—kidney cancer	0.000628	0.0206	CbGeAlD
Cyclosporine—CAMLG—nephron tubule—kidney cancer	0.000623	0.0204	CbGeAlD
Cyclosporine—FKBP4—renal system—kidney cancer	0.000623	0.0204	CbGeAlD
Cyclosporine—ABCB1—Sunitinib—kidney cancer	0.000612	0.002	CbGbCtD
Cyclosporine—SLC10A2—kidney—kidney cancer	0.000607	0.0199	CbGeAlD
Cyclosporine—FKBP4—kidney—kidney cancer	0.000602	0.0198	CbGeAlD
Cyclosporine—CYP2C19—urine—kidney cancer	0.0006	0.0197	CbGeAlD
Cyclosporine—SLC10A2—cortex of kidney—kidney cancer	0.000591	0.0194	CbGeAlD
Cyclosporine—PPID—renal system—kidney cancer	0.000575	0.0189	CbGeAlD
Cyclosporine—FKBP4—gonad—kidney cancer	0.000558	0.0183	CbGeAlD
Cyclosporine—CYP3A4—Erlotinib—kidney cancer	0.000557	0.00182	CbGbCtD
Cyclosporine—PPID—cortex of kidney—kidney cancer	0.000541	0.0178	CbGeAlD
Cyclosporine—CAMLG—cortex of kidney—kidney cancer	0.000533	0.0175	CbGeAlD
Cyclosporine—PPID—gonad—kidney cancer	0.000515	0.0169	CbGeAlD
Cyclosporine—PPID—cardiac atrium—kidney cancer	0.000515	0.0169	CbGeAlD
Cyclosporine—CYP3A4—Paclitaxel—kidney cancer	0.00051	0.00167	CbGbCtD
Cyclosporine—CAMLG—gonad—kidney cancer	0.000508	0.0167	CbGeAlD
Cyclosporine—CAMLG—cardiac atrium—kidney cancer	0.000507	0.0166	CbGeAlD
Cyclosporine—PPIA—cortex of kidney—kidney cancer	0.000486	0.0159	CbGeAlD
Cyclosporine—PPIF—Sirolimus—Temsirolimus—kidney cancer	0.000479	0.333	CbGdCrCtD
Cyclosporine—PPIF—Temsirolimus—Everolimus—kidney cancer	0.000479	0.333	CbGdCrCtD
Cyclosporine—PPIF—Sirolimus—Everolimus—kidney cancer	0.000479	0.333	CbGdCrCtD
Cyclosporine—CYP2C9—urine—kidney cancer	0.000465	0.0153	CbGeAlD
Cyclosporine—PPIF—nephron tubule—kidney cancer	0.00046	0.0151	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—kidney cancer	0.000458	0.0015	CbGbCtD
Cyclosporine—CYP3A4—Sorafenib—kidney cancer	0.000453	0.00148	CbGbCtD
Cyclosporine—CYP3A4—Vinblastine—kidney cancer	0.000447	0.00146	CbGbCtD
Cyclosporine—PPP3CA—nephron tubule—kidney cancer	0.00044	0.0144	CbGeAlD
Cyclosporine—CYP3A4—Vincristine—kidney cancer	0.000439	0.00144	CbGbCtD
Cyclosporine—PPIB—nephron tubule—kidney cancer	0.000437	0.0144	CbGeAlD
Cyclosporine—CYP2D6—Doxorubicin—kidney cancer	0.000432	0.00141	CbGbCtD
Cyclosporine—PPIF—renal system—kidney cancer	0.000418	0.0137	CbGeAlD
Cyclosporine—PPIF—kidney—kidney cancer	0.000404	0.0133	CbGeAlD
Cyclosporine—PPP3CA—renal system—kidney cancer	0.0004	0.0131	CbGeAlD
Cyclosporine—PPIB—renal system—kidney cancer	0.000398	0.013	CbGeAlD
Cyclosporine—PPIF—cortex of kidney—kidney cancer	0.000393	0.0129	CbGeAlD
Cyclosporine—PPP3CA—kidney—kidney cancer	0.000387	0.0127	CbGeAlD
Cyclosporine—PPIB—kidney—kidney cancer	0.000384	0.0126	CbGeAlD
Cyclosporine—PPP3CA—cortex of kidney—kidney cancer	0.000377	0.0124	CbGeAlD
Cyclosporine—PPIF—gonad—kidney cancer	0.000375	0.0123	CbGeAlD
Cyclosporine—PPIB—cortex of kidney—kidney cancer	0.000374	0.0123	CbGeAlD
Cyclosporine—PPIF—cardiac atrium—kidney cancer	0.000374	0.0123	CbGeAlD
Cyclosporine—CYP3A4—Sunitinib—kidney cancer	0.000367	0.0012	CbGbCtD
Cyclosporine—PPP3CA—cardiac atrium—kidney cancer	0.000358	0.0118	CbGeAlD
Cyclosporine—PPIB—gonad—kidney cancer	0.000357	0.0117	CbGeAlD
Cyclosporine—PPIB—cardiac atrium—kidney cancer	0.000356	0.0117	CbGeAlD
Cyclosporine—CYP3A4—urine—kidney cancer	0.000355	0.0116	CbGeAlD
Cyclosporine—CYP2D6—urine—kidney cancer	0.000349	0.0115	CbGeAlD
Cyclosporine—SLC10A1—renal system—kidney cancer	0.00034	0.0112	CbGeAlD
Cyclosporine—SLC10A1—kidney—kidney cancer	0.000329	0.0108	CbGeAlD
Cyclosporine—SLC22A6—nephron tubule—kidney cancer	0.000322	0.0106	CbGeAlD
Cyclosporine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000308	0.0101	CbGeAlD
Cyclosporine—SLC10A1—gonad—kidney cancer	0.000305	0.01	CbGeAlD
Cyclosporine—SLC22A6—cortex of kidney—kidney cancer	0.000276	0.00904	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—kidney cancer	0.000275	0.000899	CbGbCtD
Cyclosporine—FKBP1A—renal system—kidney cancer	0.000266	0.00872	CbGeAlD
Cyclosporine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000263	0.00864	CbGeAlD
Cyclosporine—FKBP1A—kidney—kidney cancer	0.000257	0.00843	CbGeAlD
Cyclosporine—FKBP1A—cortex of kidney—kidney cancer	0.00025	0.00821	CbGeAlD
Cyclosporine—FKBP1A—gonad—kidney cancer	0.000238	0.00782	CbGeAlD
Cyclosporine—FKBP1A—cardiac atrium—kidney cancer	0.000238	0.00781	CbGeAlD
Cyclosporine—SLCO1B1—renal system—kidney cancer	0.000225	0.0074	CbGeAlD
Cyclosporine—SLCO1B1—kidney—kidney cancer	0.000218	0.00715	CbGeAlD
Cyclosporine—ABCC3—renal system—kidney cancer	0.000214	0.00702	CbGeAlD
Cyclosporine—ABCC10—renal system—kidney cancer	0.000213	0.00699	CbGeAlD
Cyclosporine—ABCC3—kidney—kidney cancer	0.000207	0.00679	CbGeAlD
Cyclosporine—ABCC10—kidney—kidney cancer	0.000206	0.00675	CbGeAlD
Cyclosporine—ABCC10—cortex of kidney—kidney cancer	0.0002	0.00658	CbGeAlD
Cyclosporine—ABCC10—gonad—kidney cancer	0.000191	0.00627	CbGeAlD
Cyclosporine—ABCC10—cardiac atrium—kidney cancer	0.000191	0.00626	CbGeAlD
Cyclosporine—ABCC2—nephron tubule—kidney cancer	0.000188	0.00617	CbGeAlD
Cyclosporine—SLCO1A2—renal system—kidney cancer	0.000184	0.00602	CbGeAlD
Cyclosporine—SLCO1A2—kidney—kidney cancer	0.000177	0.00582	CbGeAlD
Cyclosporine—ABCC2—renal system—kidney cancer	0.000171	0.00561	CbGeAlD
Cyclosporine—ABCC2—kidney—kidney cancer	0.000165	0.00542	CbGeAlD
Cyclosporine—ABCC2—cortex of kidney—kidney cancer	0.000161	0.00528	CbGeAlD
Cyclosporine—ABCC1—cortex of kidney—kidney cancer	0.000142	0.00465	CbGeAlD
Cyclosporine—ABCG2—nephron tubule—kidney cancer	0.000137	0.0045	CbGeAlD
Cyclosporine—ABCC1—cardiac atrium—kidney cancer	0.000135	0.00443	CbGeAlD
Cyclosporine—CYP2C8—renal system—kidney cancer	0.000128	0.00421	CbGeAlD
Cyclosporine—CYP3A5—nephron tubule—kidney cancer	0.000127	0.00418	CbGeAlD
Cyclosporine—CYP2C8—kidney—kidney cancer	0.000124	0.00407	CbGeAlD
Cyclosporine—CYP3A5—renal system—kidney cancer	0.000116	0.0038	CbGeAlD
Cyclosporine—CYP3A5—kidney—kidney cancer	0.000112	0.00367	CbGeAlD
Cyclosporine—CYP3A5—cortex of kidney—kidney cancer	0.000109	0.00358	CbGeAlD
Cyclosporine—CYP3A4—renal system—kidney cancer	8.68e-05	0.00285	CbGeAlD
Cyclosporine—CYP2D6—renal system—kidney cancer	8.55e-05	0.0028	CbGeAlD
Cyclosporine—CYP3A4—kidney—kidney cancer	8.4e-05	0.00276	CbGeAlD
Cyclosporine—CYP2D6—kidney—kidney cancer	8.26e-05	0.00271	CbGeAlD
Cyclosporine—ABCB1—nephron tubule—kidney cancer	6.76e-05	0.00222	CbGeAlD
Cyclosporine—ABCB1—renal system—kidney cancer	6.15e-05	0.00202	CbGeAlD
Cyclosporine—ABCB1—kidney—kidney cancer	5.94e-05	0.00195	CbGeAlD
Cyclosporine—ABCB1—cortex of kidney—kidney cancer	5.79e-05	0.0019	CbGeAlD
Cyclosporine—ABCB1—gonad—kidney cancer	5.51e-05	0.00181	CbGeAlD
Cyclosporine—Mediastinal disorder—Capecitabine—kidney cancer	1.8e-05	0.000223	CcSEcCtD
Cyclosporine—Anxiety—Paclitaxel—kidney cancer	1.8e-05	0.000222	CcSEcCtD
Cyclosporine—Decreased appetite—Gemcitabine—kidney cancer	1.79e-05	0.000222	CcSEcCtD
Cyclosporine—Hypersensitivity—Dactinomycin—kidney cancer	1.79e-05	0.000222	CcSEcCtD
Cyclosporine—Chills—Capecitabine—kidney cancer	1.79e-05	0.000222	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	1.79e-05	0.000222	CcSEcCtD
Cyclosporine—Arrhythmia—Capecitabine—kidney cancer	1.78e-05	0.000221	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Gemcitabine—kidney cancer	1.78e-05	0.000221	CcSEcCtD
Cyclosporine—Discomfort—Paclitaxel—kidney cancer	1.78e-05	0.000221	CcSEcCtD
Cyclosporine—Fatigue—Gemcitabine—kidney cancer	1.78e-05	0.00022	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Vincristine—kidney cancer	1.78e-05	0.00022	CcSEcCtD
Cyclosporine—Dizziness—Sorafenib—kidney cancer	1.77e-05	0.000219	CcSEcCtD
Cyclosporine—Pain—Gemcitabine—kidney cancer	1.77e-05	0.000219	CcSEcCtD
Cyclosporine—Constipation—Gemcitabine—kidney cancer	1.77e-05	0.000219	CcSEcCtD
Cyclosporine—Nausea—Erlotinib—kidney cancer	1.77e-05	0.000219	CcSEcCtD
Cyclosporine—Alopecia—Capecitabine—kidney cancer	1.76e-05	0.000218	CcSEcCtD
Cyclosporine—Dry mouth—Paclitaxel—kidney cancer	1.76e-05	0.000218	CcSEcCtD
Cyclosporine—Mood swings—Doxorubicin—kidney cancer	1.76e-05	0.000218	CcSEcCtD
Cyclosporine—Diarrhoea—Sunitinib—kidney cancer	1.76e-05	0.000218	CcSEcCtD
Cyclosporine—Mental disorder—Capecitabine—kidney cancer	1.75e-05	0.000217	CcSEcCtD
Cyclosporine—Asthenia—Dactinomycin—kidney cancer	1.75e-05	0.000216	CcSEcCtD
Cyclosporine—Confusional state—Paclitaxel—kidney cancer	1.74e-05	0.000216	CcSEcCtD
Cyclosporine—Blood creatinine increased—Doxorubicin—kidney cancer	1.74e-05	0.000216	CcSEcCtD
Cyclosporine—Malnutrition—Capecitabine—kidney cancer	1.74e-05	0.000215	CcSEcCtD
Cyclosporine—Anaphylactic shock—Paclitaxel—kidney cancer	1.73e-05	0.000214	CcSEcCtD
Cyclosporine—Oedema—Paclitaxel—kidney cancer	1.73e-05	0.000214	CcSEcCtD
Cyclosporine—Abdominal pain—Vincristine—kidney cancer	1.72e-05	0.000213	CcSEcCtD
Cyclosporine—Body temperature increased—Vincristine—kidney cancer	1.72e-05	0.000213	CcSEcCtD
Cyclosporine—Infection—Paclitaxel—kidney cancer	1.72e-05	0.000213	CcSEcCtD
Cyclosporine—Flatulence—Capecitabine—kidney cancer	1.71e-05	0.000212	CcSEcCtD
Cyclosporine—Dry skin—Doxorubicin—kidney cancer	1.71e-05	0.000211	CcSEcCtD
Cyclosporine—Dysgeusia—Capecitabine—kidney cancer	1.7e-05	0.000211	CcSEcCtD
Cyclosporine—Dizziness—Sunitinib—kidney cancer	1.7e-05	0.000211	CcSEcCtD
Cyclosporine—Feeling abnormal—Gemcitabine—kidney cancer	1.7e-05	0.000211	CcSEcCtD
Cyclosporine—Vomiting—Sorafenib—kidney cancer	1.7e-05	0.000211	CcSEcCtD
Cyclosporine—Abdominal pain upper—Doxorubicin—kidney cancer	1.7e-05	0.00021	CcSEcCtD
Cyclosporine—Nervous system disorder—Paclitaxel—kidney cancer	1.69e-05	0.00021	CcSEcCtD
Cyclosporine—Thrombocytopenia—Paclitaxel—kidney cancer	1.69e-05	0.00021	CcSEcCtD
Cyclosporine—Rash—Sorafenib—kidney cancer	1.69e-05	0.000209	CcSEcCtD
Cyclosporine—Dermatitis—Sorafenib—kidney cancer	1.68e-05	0.000209	CcSEcCtD
Cyclosporine—Breast disorder—Doxorubicin—kidney cancer	1.68e-05	0.000208	CcSEcCtD
Cyclosporine—Skin disorder—Paclitaxel—kidney cancer	1.68e-05	0.000208	CcSEcCtD
Cyclosporine—Headache—Sorafenib—kidney cancer	1.67e-05	0.000207	CcSEcCtD
Cyclosporine—Muscle spasms—Capecitabine—kidney cancer	1.67e-05	0.000207	CcSEcCtD
Cyclosporine—Hyperhidrosis—Paclitaxel—kidney cancer	1.67e-05	0.000207	CcSEcCtD
Cyclosporine—Diarrhoea—Dactinomycin—kidney cancer	1.67e-05	0.000206	CcSEcCtD
Cyclosporine—Anorexia—Paclitaxel—kidney cancer	1.65e-05	0.000204	CcSEcCtD
Cyclosporine—Gastritis—Doxorubicin—kidney cancer	1.65e-05	0.000204	CcSEcCtD
Cyclosporine—Muscular weakness—Doxorubicin—kidney cancer	1.64e-05	0.000203	CcSEcCtD
Cyclosporine—Vision blurred—Capecitabine—kidney cancer	1.64e-05	0.000203	CcSEcCtD
Cyclosporine—Vomiting—Sunitinib—kidney cancer	1.64e-05	0.000203	CcSEcCtD
Cyclosporine—Body temperature increased—Gemcitabine—kidney cancer	1.63e-05	0.000202	CcSEcCtD
Cyclosporine—Tremor—Capecitabine—kidney cancer	1.63e-05	0.000202	CcSEcCtD
Cyclosporine—Rash—Sunitinib—kidney cancer	1.62e-05	0.000201	CcSEcCtD
Cyclosporine—Dermatitis—Sunitinib—kidney cancer	1.62e-05	0.000201	CcSEcCtD
Cyclosporine—Abdominal distension—Doxorubicin—kidney cancer	1.62e-05	0.0002	CcSEcCtD
Cyclosporine—Ill-defined disorder—Capecitabine—kidney cancer	1.61e-05	0.0002	CcSEcCtD
Cyclosporine—Headache—Sunitinib—kidney cancer	1.61e-05	0.0002	CcSEcCtD
Cyclosporine—Dysphagia—Doxorubicin—kidney cancer	1.61e-05	0.000199	CcSEcCtD
Cyclosporine—Anaemia—Capecitabine—kidney cancer	1.61e-05	0.000199	CcSEcCtD
Cyclosporine—Hypersensitivity—Vincristine—kidney cancer	1.6e-05	0.000199	CcSEcCtD
Cyclosporine—Nausea—Sorafenib—kidney cancer	1.59e-05	0.000197	CcSEcCtD
Cyclosporine—Pancreatitis—Doxorubicin—kidney cancer	1.58e-05	0.000195	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.57e-05	0.000195	CcSEcCtD
Cyclosporine—Malaise—Capecitabine—kidney cancer	1.57e-05	0.000194	CcSEcCtD
Cyclosporine—Insomnia—Paclitaxel—kidney cancer	1.56e-05	0.000194	CcSEcCtD
Cyclosporine—Vertigo—Capecitabine—kidney cancer	1.56e-05	0.000193	CcSEcCtD
Cyclosporine—Asthenia—Vincristine—kidney cancer	1.56e-05	0.000193	CcSEcCtD
Cyclosporine—Leukopenia—Capecitabine—kidney cancer	1.56e-05	0.000193	CcSEcCtD
Cyclosporine—Paraesthesia—Paclitaxel—kidney cancer	1.55e-05	0.000192	CcSEcCtD
Cyclosporine—Vomiting—Dactinomycin—kidney cancer	1.55e-05	0.000192	CcSEcCtD
Cyclosporine—Bronchitis—Doxorubicin—kidney cancer	1.55e-05	0.000191	CcSEcCtD
Cyclosporine—Dyspnoea—Paclitaxel—kidney cancer	1.54e-05	0.000191	CcSEcCtD
Cyclosporine—Somnolence—Paclitaxel—kidney cancer	1.54e-05	0.00019	CcSEcCtD
Cyclosporine—Rash—Dactinomycin—kidney cancer	1.54e-05	0.00019	CcSEcCtD
Cyclosporine—Nausea—Sunitinib—kidney cancer	1.53e-05	0.000189	CcSEcCtD
Cyclosporine—Dyspepsia—Paclitaxel—kidney cancer	1.52e-05	0.000188	CcSEcCtD
Cyclosporine—Cough—Capecitabine—kidney cancer	1.52e-05	0.000188	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—kidney cancer	1.5e-05	0.000186	CcSEcCtD
Cyclosporine—Decreased appetite—Paclitaxel—kidney cancer	1.5e-05	0.000186	CcSEcCtD
Cyclosporine—Hypertension—Capecitabine—kidney cancer	1.5e-05	0.000186	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—kidney cancer	1.49e-05	0.000185	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.49e-05	0.000185	CcSEcCtD
Cyclosporine—Fatigue—Paclitaxel—kidney cancer	1.49e-05	0.000185	CcSEcCtD
Cyclosporine—Diarrhoea—Vincristine—kidney cancer	1.49e-05	0.000184	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—kidney cancer	1.49e-05	0.000184	CcSEcCtD
Cyclosporine—Asthenia—Gemcitabine—kidney cancer	1.48e-05	0.000183	CcSEcCtD
Cyclosporine—Myalgia—Capecitabine—kidney cancer	1.48e-05	0.000183	CcSEcCtD
Cyclosporine—Arthralgia—Capecitabine—kidney cancer	1.48e-05	0.000183	CcSEcCtD
Cyclosporine—Chest pain—Capecitabine—kidney cancer	1.48e-05	0.000183	CcSEcCtD
Cyclosporine—Pain—Paclitaxel—kidney cancer	1.48e-05	0.000183	CcSEcCtD
Cyclosporine—Constipation—Paclitaxel—kidney cancer	1.48e-05	0.000183	CcSEcCtD
Cyclosporine—Anxiety—Capecitabine—kidney cancer	1.47e-05	0.000183	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	1.47e-05	0.000182	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—kidney cancer	1.46e-05	0.000181	CcSEcCtD
Cyclosporine—Discomfort—Capecitabine—kidney cancer	1.46e-05	0.000181	CcSEcCtD
Cyclosporine—Pruritus—Gemcitabine—kidney cancer	1.46e-05	0.000181	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—kidney cancer	1.45e-05	0.00018	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—kidney cancer	1.45e-05	0.00018	CcSEcCtD
Cyclosporine—Dry mouth—Capecitabine—kidney cancer	1.45e-05	0.000179	CcSEcCtD
Cyclosporine—Nausea—Dactinomycin—kidney cancer	1.45e-05	0.000179	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—kidney cancer	1.44e-05	0.000179	CcSEcCtD
Cyclosporine—Dizziness—Vincristine—kidney cancer	1.44e-05	0.000178	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—kidney cancer	1.43e-05	0.000178	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—kidney cancer	1.43e-05	0.000178	CcSEcCtD
Cyclosporine—Confusional state—Capecitabine—kidney cancer	1.43e-05	0.000177	CcSEcCtD
Cyclosporine—Feeling abnormal—Paclitaxel—kidney cancer	1.42e-05	0.000176	CcSEcCtD
Cyclosporine—Oedema—Capecitabine—kidney cancer	1.42e-05	0.000176	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Paclitaxel—kidney cancer	1.41e-05	0.000175	CcSEcCtD
Cyclosporine—Diarrhoea—Gemcitabine—kidney cancer	1.41e-05	0.000175	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—kidney cancer	1.41e-05	0.000175	CcSEcCtD
Cyclosporine—Infection—Capecitabine—kidney cancer	1.41e-05	0.000174	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—kidney cancer	1.41e-05	0.000174	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—kidney cancer	1.4e-05	0.000173	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—kidney cancer	1.4e-05	0.000173	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—kidney cancer	1.39e-05	0.000173	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—kidney cancer	1.39e-05	0.000173	CcSEcCtD
Cyclosporine—Nervous system disorder—Capecitabine—kidney cancer	1.39e-05	0.000172	CcSEcCtD
Cyclosporine—Thrombocytopenia—Capecitabine—kidney cancer	1.39e-05	0.000172	CcSEcCtD
Cyclosporine—Vomiting—Vincristine—kidney cancer	1.38e-05	0.000171	CcSEcCtD
Cyclosporine—Skin disorder—Capecitabine—kidney cancer	1.38e-05	0.000171	CcSEcCtD
Cyclosporine—Urticaria—Paclitaxel—kidney cancer	1.37e-05	0.00017	CcSEcCtD
Cyclosporine—Rash—Vincristine—kidney cancer	1.37e-05	0.00017	CcSEcCtD
Cyclosporine—Hyperhidrosis—Capecitabine—kidney cancer	1.37e-05	0.00017	CcSEcCtD
Cyclosporine—Dermatitis—Vincristine—kidney cancer	1.37e-05	0.00017	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—kidney cancer	1.37e-05	0.000169	CcSEcCtD
Cyclosporine—Abdominal pain—Paclitaxel—kidney cancer	1.37e-05	0.000169	CcSEcCtD
Cyclosporine—Body temperature increased—Paclitaxel—kidney cancer	1.37e-05	0.000169	CcSEcCtD
Cyclosporine—Headache—Vincristine—kidney cancer	1.36e-05	0.000169	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—kidney cancer	1.36e-05	0.000168	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—kidney cancer	1.35e-05	0.000167	CcSEcCtD
Cyclosporine—Anorexia—Capecitabine—kidney cancer	1.35e-05	0.000167	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—kidney cancer	1.34e-05	0.000167	CcSEcCtD
Cyclosporine—Vomiting—Gemcitabine—kidney cancer	1.31e-05	0.000163	CcSEcCtD
Cyclosporine—Rash—Gemcitabine—kidney cancer	1.3e-05	0.000161	CcSEcCtD
Cyclosporine—Dermatitis—Gemcitabine—kidney cancer	1.3e-05	0.000161	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—kidney cancer	1.29e-05	0.00016	CcSEcCtD
Cyclosporine—Headache—Gemcitabine—kidney cancer	1.29e-05	0.00016	CcSEcCtD
Cyclosporine—Nausea—Vincristine—kidney cancer	1.29e-05	0.00016	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.29e-05	0.00016	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—kidney cancer	1.29e-05	0.00016	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—kidney cancer	1.29e-05	0.000159	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—kidney cancer	1.29e-05	0.000159	CcSEcCtD
Cyclosporine—Insomnia—Capecitabine—kidney cancer	1.28e-05	0.000159	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—kidney cancer	1.28e-05	0.000159	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—kidney cancer	1.28e-05	0.000158	CcSEcCtD
Cyclosporine—Paraesthesia—Capecitabine—kidney cancer	1.27e-05	0.000158	CcSEcCtD
Cyclosporine—Hypersensitivity—Paclitaxel—kidney cancer	1.27e-05	0.000158	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—kidney cancer	1.27e-05	0.000157	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—kidney cancer	1.26e-05	0.000157	CcSEcCtD
Cyclosporine—Dyspnoea—Capecitabine—kidney cancer	1.26e-05	0.000157	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—kidney cancer	1.26e-05	0.000156	CcSEcCtD
Cyclosporine—Dyspepsia—Capecitabine—kidney cancer	1.25e-05	0.000155	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—kidney cancer	1.24e-05	0.000154	CcSEcCtD
Cyclosporine—Asthenia—Paclitaxel—kidney cancer	1.24e-05	0.000154	CcSEcCtD
Cyclosporine—Decreased appetite—Capecitabine—kidney cancer	1.23e-05	0.000153	CcSEcCtD
Cyclosporine—Nausea—Gemcitabine—kidney cancer	1.23e-05	0.000152	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Capecitabine—kidney cancer	1.22e-05	0.000152	CcSEcCtD
Cyclosporine—Fatigue—Capecitabine—kidney cancer	1.22e-05	0.000151	CcSEcCtD
Cyclosporine—Pruritus—Paclitaxel—kidney cancer	1.22e-05	0.000151	CcSEcCtD
Cyclosporine—Pain—Capecitabine—kidney cancer	1.21e-05	0.00015	CcSEcCtD
Cyclosporine—Constipation—Capecitabine—kidney cancer	1.21e-05	0.00015	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—kidney cancer	1.2e-05	0.000149	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—kidney cancer	1.19e-05	0.000148	CcSEcCtD
Cyclosporine—Diarrhoea—Paclitaxel—kidney cancer	1.18e-05	0.000146	CcSEcCtD
Cyclosporine—Feeling abnormal—Capecitabine—kidney cancer	1.17e-05	0.000145	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—kidney cancer	1.17e-05	0.000145	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Capecitabine—kidney cancer	1.16e-05	0.000144	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—kidney cancer	1.16e-05	0.000144	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—kidney cancer	1.15e-05	0.000143	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—kidney cancer	1.15e-05	0.000142	CcSEcCtD
Cyclosporine—Dizziness—Paclitaxel—kidney cancer	1.14e-05	0.000142	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—kidney cancer	1.14e-05	0.000141	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—kidney cancer	1.13e-05	0.00014	CcSEcCtD
Cyclosporine—Urticaria—Capecitabine—kidney cancer	1.13e-05	0.00014	CcSEcCtD
Cyclosporine—Abdominal pain—Capecitabine—kidney cancer	1.12e-05	0.000139	CcSEcCtD
Cyclosporine—Body temperature increased—Capecitabine—kidney cancer	1.12e-05	0.000139	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—kidney cancer	1.12e-05	0.000139	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—kidney cancer	1.1e-05	0.000137	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—kidney cancer	1.1e-05	0.000136	CcSEcCtD
Cyclosporine—Vomiting—Paclitaxel—kidney cancer	1.1e-05	0.000136	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—kidney cancer	1.1e-05	0.000136	CcSEcCtD
Cyclosporine—Rash—Paclitaxel—kidney cancer	1.09e-05	0.000135	CcSEcCtD
Cyclosporine—Dermatitis—Paclitaxel—kidney cancer	1.09e-05	0.000135	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—kidney cancer	1.09e-05	0.000135	CcSEcCtD
Cyclosporine—Headache—Paclitaxel—kidney cancer	1.08e-05	0.000134	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—kidney cancer	1.08e-05	0.000133	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—kidney cancer	1.06e-05	0.000131	CcSEcCtD
Cyclosporine—Hypersensitivity—Capecitabine—kidney cancer	1.04e-05	0.000129	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—kidney cancer	1.04e-05	0.000129	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—kidney cancer	1.04e-05	0.000128	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—kidney cancer	1.03e-05	0.000127	CcSEcCtD
Cyclosporine—Nausea—Paclitaxel—kidney cancer	1.03e-05	0.000127	CcSEcCtD
Cyclosporine—Asthenia—Capecitabine—kidney cancer	1.02e-05	0.000126	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—kidney cancer	1.01e-05	0.000125	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—kidney cancer	1.01e-05	0.000125	CcSEcCtD
Cyclosporine—Pruritus—Capecitabine—kidney cancer	1e-05	0.000124	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—kidney cancer	1e-05	0.000124	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—kidney cancer	9.78e-06	0.000121	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—kidney cancer	9.71e-06	0.00012	CcSEcCtD
Cyclosporine—Diarrhoea—Capecitabine—kidney cancer	9.7e-06	0.00012	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—kidney cancer	9.67e-06	0.00012	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—kidney cancer	9.54e-06	0.000118	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—kidney cancer	9.54e-06	0.000118	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—kidney cancer	9.54e-06	0.000118	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—kidney cancer	9.5e-06	0.000118	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.47e-06	0.000117	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—kidney cancer	9.42e-06	0.000117	CcSEcCtD
Cyclosporine—Dizziness—Capecitabine—kidney cancer	9.38e-06	0.000116	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—kidney cancer	9.33e-06	0.000116	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—kidney cancer	9.22e-06	0.000114	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—kidney cancer	9.14e-06	0.000113	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—kidney cancer	9.14e-06	0.000113	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—kidney cancer	9.08e-06	0.000112	CcSEcCtD
Cyclosporine—Vomiting—Capecitabine—kidney cancer	9.02e-06	0.000112	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—kidney cancer	8.97e-06	0.000111	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—kidney cancer	8.95e-06	0.000111	CcSEcCtD
Cyclosporine—Rash—Capecitabine—kidney cancer	8.94e-06	0.000111	CcSEcCtD
Cyclosporine—Dermatitis—Capecitabine—kidney cancer	8.93e-06	0.000111	CcSEcCtD
Cyclosporine—Headache—Capecitabine—kidney cancer	8.89e-06	0.00011	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—kidney cancer	8.88e-06	0.00011	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—kidney cancer	8.84e-06	0.000109	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—kidney cancer	8.72e-06	0.000108	CcSEcCtD
Cyclosporine—Nausea—Capecitabine—kidney cancer	8.42e-06	0.000104	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.33e-06	0.000103	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—kidney cancer	8.27e-06	0.000102	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—kidney cancer	8.21e-06	0.000102	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—kidney cancer	8.15e-06	0.000101	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—kidney cancer	8.13e-06	0.000101	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—kidney cancer	8.05e-06	9.97e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—kidney cancer	7.95e-06	9.84e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.89e-06	9.77e-05	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—kidney cancer	7.88e-06	9.76e-05	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—kidney cancer	7.82e-06	9.68e-05	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—kidney cancer	7.82e-06	9.68e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—kidney cancer	7.53e-06	9.33e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—kidney cancer	7.48e-06	9.26e-05	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—kidney cancer	7.26e-06	8.99e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—kidney cancer	7.23e-06	8.95e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—kidney cancer	7.23e-06	8.95e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—kidney cancer	6.74e-06	8.34e-05	CcSEcCtD
Cyclosporine—Asthenia—Doxorubicin—kidney cancer	6.56e-06	8.12e-05	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—kidney cancer	6.47e-06	8.01e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—kidney cancer	6.26e-06	7.75e-05	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—kidney cancer	6.05e-06	7.49e-05	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—kidney cancer	5.81e-06	7.2e-05	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—kidney cancer	5.76e-06	7.14e-05	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—kidney cancer	5.76e-06	7.13e-05	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—kidney cancer	5.73e-06	7.09e-05	CcSEcCtD
Cyclosporine—Nausea—Doxorubicin—kidney cancer	5.43e-06	6.73e-05	CcSEcCtD
Cyclosporine—ABCC1—Metabolism—ABCB1—kidney cancer	2.17e-06	5.41e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.15e-06	5.37e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CRABP1—kidney cancer	2.13e-06	5.32e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HIF1A—kidney cancer	2.12e-06	5.29e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TSC2—kidney cancer	2.11e-06	5.28e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GSTM1—kidney cancer	2.11e-06	5.26e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.09e-06	5.22e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPAT—kidney cancer	2.09e-06	5.21e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.09e-06	5.21e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ACHE—kidney cancer	2.08e-06	5.2e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTT1—kidney cancer	2.08e-06	5.2e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MAPK3—kidney cancer	2.08e-06	5.18e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ABCB1—kidney cancer	2.06e-06	5.15e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CA9—kidney cancer	2.06e-06	5.13e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CA9—kidney cancer	2.04e-06	5.09e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.03e-06	5.08e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MYC—kidney cancer	2.02e-06	5.04e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GSTP1—kidney cancer	2.02e-06	5.03e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—RAF1—kidney cancer	2.02e-06	5.03e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—RELA—kidney cancer	2.01e-06	5.01e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—GSTM1—kidney cancer	2e-06	4.99e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GSTP1—kidney cancer	2e-06	4.99e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—CYP1A1—kidney cancer	2e-06	4.98e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ERBB2—kidney cancer	1.99e-06	4.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.99e-06	4.97e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—VEGFA—kidney cancer	1.98e-06	4.95e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—POMC—kidney cancer	1.98e-06	4.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ITPR2—kidney cancer	1.98e-06	4.94e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MAPK1—kidney cancer	1.97e-06	4.93e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—SCARB1—kidney cancer	1.97e-06	4.92e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MTOR—kidney cancer	1.97e-06	4.91e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS1—kidney cancer	1.95e-06	4.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—FH—kidney cancer	1.94e-06	4.84e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—APRT—kidney cancer	1.94e-06	4.84e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PSMD7—kidney cancer	1.92e-06	4.78e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ABCB1—kidney cancer	1.91e-06	4.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CRABP1—kidney cancer	1.9e-06	4.74e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—POMC—kidney cancer	1.9e-06	4.74e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CYP1A1—kidney cancer	1.9e-06	4.74e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ABCB1—kidney cancer	1.89e-06	4.72e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MAPK3—kidney cancer	1.87e-06	4.68e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.87e-06	4.66e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—APC—kidney cancer	1.87e-06	4.66e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KIT—kidney cancer	1.87e-06	4.66e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—kidney cancer	1.87e-06	4.66e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CRABP1—kidney cancer	1.86e-06	4.63e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GSTM1—kidney cancer	1.85e-06	4.62e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CDKN1B—kidney cancer	1.85e-06	4.61e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GSTM1—kidney cancer	1.84e-06	4.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.83e-06	4.56e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GPC3—kidney cancer	1.82e-06	4.55e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—kidney cancer	1.82e-06	4.55e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.82e-06	4.55e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—BCHE—kidney cancer	1.82e-06	4.53e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—kidney cancer	1.81e-06	4.51e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.81e-06	4.51e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTT1—kidney cancer	1.81e-06	4.51e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ACHE—kidney cancer	1.81e-06	4.51e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.79e-06	4.48e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MAPK1—kidney cancer	1.78e-06	4.45e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CA2—kidney cancer	1.77e-06	4.43e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ITPR2—kidney cancer	1.77e-06	4.41e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCND1—kidney cancer	1.76e-06	4.4e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—JUN—kidney cancer	1.76e-06	4.39e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CYP1A1—kidney cancer	1.76e-06	4.38e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—BRAF—kidney cancer	1.76e-06	4.38e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.75e-06	4.36e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CTNNB1—kidney cancer	1.75e-06	4.36e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CYP1A1—kidney cancer	1.74e-06	4.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CRABP1—kidney cancer	1.73e-06	4.33e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.73e-06	4.32e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALAD—kidney cancer	1.73e-06	4.31e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ITPR2—kidney cancer	1.72e-06	4.3e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PIK3CA—kidney cancer	1.71e-06	4.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SCARB1—kidney cancer	1.71e-06	4.27e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTEN—kidney cancer	1.7e-06	4.25e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS1—kidney cancer	1.69e-06	4.22e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.69e-06	4.21e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—kidney cancer	1.68e-06	4.2e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PSMD7—kidney cancer	1.66e-06	4.14e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—POMC—kidney cancer	1.65e-06	4.13e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PIK3CA—kidney cancer	1.65e-06	4.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.65e-06	4.12e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.64e-06	4.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.63e-06	4.07e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.63e-06	4.06e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTT1—kidney cancer	1.61e-06	4.02e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ACHE—kidney cancer	1.61e-06	4.02e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ITPR2—kidney cancer	1.61e-06	4.02e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PGK1—kidney cancer	1.58e-06	3.95e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.58e-06	3.95e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—kidney cancer	1.58e-06	3.94e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTT1—kidney cancer	1.57e-06	3.93e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ACHE—kidney cancer	1.57e-06	3.93e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—BCHE—kidney cancer	1.57e-06	3.93e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.56e-06	3.89e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.55e-06	3.88e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—LDHB—kidney cancer	1.55e-06	3.87e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—kidney cancer	1.55e-06	3.86e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—kidney cancer	1.54e-06	3.83e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SCARB1—kidney cancer	1.53e-06	3.81e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—kidney cancer	1.52e-06	3.78e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS1—kidney cancer	1.51e-06	3.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.5e-06	3.74e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—kidney cancer	1.5e-06	3.74e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SCARB1—kidney cancer	1.49e-06	3.72e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—POMC—kidney cancer	1.49e-06	3.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.49e-06	3.71e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.48e-06	3.7e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ACHE—kidney cancer	1.48e-06	3.7e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PSMD7—kidney cancer	1.48e-06	3.7e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS1—kidney cancer	1.47e-06	3.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTT1—kidney cancer	1.47e-06	3.67e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ACHE—kidney cancer	1.47e-06	3.67e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—RAF1—kidney cancer	1.47e-06	3.66e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.46e-06	3.63e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK3—kidney cancer	1.45e-06	3.63e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERBB2—kidney cancer	1.45e-06	3.62e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PSMD7—kidney cancer	1.45e-06	3.61e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTP1—kidney cancer	1.44e-06	3.61e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MTOR—kidney cancer	1.43e-06	3.57e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD4—kidney cancer	1.43e-06	3.56e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—kidney cancer	1.42e-06	3.54e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—POMC—kidney cancer	1.41e-06	3.53e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—kidney cancer	1.41e-06	3.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—BCHE—kidney cancer	1.4e-06	3.5e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SCARB1—kidney cancer	1.4e-06	3.5e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SCARB1—kidney cancer	1.39e-06	3.47e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS1—kidney cancer	1.39e-06	3.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.39e-06	3.46e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK1—kidney cancer	1.38e-06	3.45e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTEN—kidney cancer	1.38e-06	3.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS1—kidney cancer	1.38e-06	3.44e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—BCHE—kidney cancer	1.37e-06	3.42e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ABCB1—kidney cancer	1.37e-06	3.41e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.36e-06	3.4e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SLC5A5—kidney cancer	1.35e-06	3.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PSMD7—kidney cancer	1.35e-06	3.37e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CA9—kidney cancer	1.34e-06	3.36e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1B—kidney cancer	1.34e-06	3.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.34e-06	3.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTM1—kidney cancer	1.33e-06	3.31e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTEN—kidney cancer	1.32e-06	3.3e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—kidney cancer	1.32e-06	3.29e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—POMC—kidney cancer	1.31e-06	3.27e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SLC2A1—kidney cancer	1.31e-06	3.26e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—kidney cancer	1.31e-06	3.26e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.3e-06	3.24e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—POMC—kidney cancer	1.3e-06	3.24e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—BCHE—kidney cancer	1.29e-06	3.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—BCHE—kidney cancer	1.28e-06	3.19e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.28e-06	3.18e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.27e-06	3.17e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CTNNB1—kidney cancer	1.27e-06	3.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.26e-06	3.16e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.26e-06	3.14e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTP1—kidney cancer	1.25e-06	3.12e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.25e-06	3.11e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTEN—kidney cancer	1.24e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.23e-06	3.07e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.22e-06	3.05e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—kidney cancer	1.2e-06	3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—kidney cancer	1.19e-06	2.96e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.18e-06	2.96e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ABCB1—kidney cancer	1.18e-06	2.96e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—kidney cancer	1.16e-06	2.9e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—kidney cancer	1.15e-06	2.87e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTM1—kidney cancer	1.15e-06	2.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CRABP1—kidney cancer	1.14e-06	2.85e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.13e-06	2.83e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—kidney cancer	1.13e-06	2.82e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTP1—kidney cancer	1.12e-06	2.79e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTP1—kidney cancer	1.09e-06	2.72e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.09e-06	2.72e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ITPR2—kidney cancer	1.06e-06	2.65e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ABCB1—kidney cancer	1.06e-06	2.64e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK3—kidney cancer	1.06e-06	2.64e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—kidney cancer	1.04e-06	2.61e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—kidney cancer	1.04e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—kidney cancer	1.04e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.03e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—kidney cancer	1.03e-06	2.56e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTP1—kidney cancer	1.03e-06	2.56e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTM1—kidney cancer	1.03e-06	2.56e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTP1—kidney cancer	1.02e-06	2.54e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK1—kidney cancer	1.01e-06	2.51e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTM1—kidney cancer	1e-06	2.5e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—kidney cancer	9.84e-07	2.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP1A1—kidney cancer	9.73e-07	2.43e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ABCB1—kidney cancer	9.73e-07	2.43e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—kidney cancer	9.72e-07	2.43e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTT1—kidney cancer	9.69e-07	2.42e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ACHE—kidney cancer	9.69e-07	2.42e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ABCB1—kidney cancer	9.64e-07	2.41e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP1A1—kidney cancer	9.5e-07	2.37e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—kidney cancer	9.49e-07	2.37e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTM1—kidney cancer	9.44e-07	2.36e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—POMC—kidney cancer	9.38e-07	2.34e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTM1—kidney cancer	9.36e-07	2.34e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—kidney cancer	9.32e-07	2.33e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SCARB1—kidney cancer	9.17e-07	2.29e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—kidney cancer	9.11e-07	2.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS1—kidney cancer	9.08e-07	2.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—kidney cancer	9.03e-07	2.25e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.96e-07	2.24e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP1A1—kidney cancer	8.95e-07	2.23e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PSMD7—kidney cancer	8.91e-07	2.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP1A1—kidney cancer	8.87e-07	2.21e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—kidney cancer	8.72e-07	2.18e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—BCHE—kidney cancer	8.44e-07	2.11e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.34e-07	2.08e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—POMC—kidney cancer	8.13e-07	2.03e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—kidney cancer	8.12e-07	2.03e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.05e-07	2.01e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.99e-07	2e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—kidney cancer	7.49e-07	1.87e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—kidney cancer	7.3e-07	1.82e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.29e-07	1.82e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—POMC—kidney cancer	7.26e-07	1.81e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—POMC—kidney cancer	7.08e-07	1.77e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—kidney cancer	6.94e-07	1.73e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTP1—kidney cancer	6.72e-07	1.68e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—POMC—kidney cancer	6.67e-07	1.67e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—POMC—kidney cancer	6.62e-07	1.65e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—kidney cancer	6.53e-07	1.63e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—kidney cancer	6.48e-07	1.62e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—kidney cancer	6.43e-07	1.6e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—kidney cancer	6.37e-07	1.59e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCB1—kidney cancer	6.36e-07	1.59e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTM1—kidney cancer	6.17e-07	1.54e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.85e-07	1.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—kidney cancer	5.79e-07	1.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—kidney cancer	5.65e-07	1.41e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—kidney cancer	5.65e-07	1.41e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—kidney cancer	5.32e-07	1.33e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—kidney cancer	5.28e-07	1.32e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—kidney cancer	5.05e-07	1.26e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—kidney cancer	4.93e-07	1.23e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—kidney cancer	4.64e-07	1.16e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—kidney cancer	4.61e-07	1.15e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—kidney cancer	4.6e-07	1.15e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—POMC—kidney cancer	4.36e-07	1.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.99e-07	9.96e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.56e-07	8.89e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—kidney cancer	3.48e-07	8.69e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—kidney cancer	3.48e-07	8.67e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.27e-07	8.17e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.25e-07	8.1e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—kidney cancer	3.03e-07	7.57e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.14e-07	5.34e-06	CbGpPWpGaD
